Liposomal amphotericin B activates antifungal resistance with reduced toxicity by diverting Toll-like receptor signalling from TLR-2 to TLR-4-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Liposomal amphotericin B activates antifungal resistance with reduced toxicity by diverting Toll-like receptor signalling from TLR-2 to TLR-4

Published:2005-02-01 Issue:2 Volume:55 Page:214-222
ISSN:1460-2091
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Bellocchio Silvia,Gaziano Roberta,Bozza Silvia,Rossi Giordano,Montagnoli Claudia,Perruccio Katia,Calvitti Mario,Pitzurra Lucia,Romani Luigina

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/55/2/214/2544704/dkh542.pdf

Reference39 articles.

1. Marr, K. A., Patterson, T. M. & Denning, D. W. (2002). Aspergillosis. Pathogenesis, clinical manifestations, and therapy. Infectious Disease Clinics of North America16, 875–94.

2. Steinbach, W. J. & Stevens, D. A. (2003). Review of newer antifungal and immunomodulatory strategies for invasive aspergillosis. Clinical Infectious Diseases37, 157–87.

3. Denning, D. W. (1996). Therapeutic outcome in invasive aspergillosis. Clinical Infectious Diseases23, 608–15.

4. Gallis, H. A., Drew, R. H. & Pickard, W. W. (1990). Amphotericin B: 30 years of clinical experience. Review of Infectious Diseases12, 308–29.

5. Hiemenz, J. W. & Walsh, T. J. (1996). Lipid formulations of amphotericin B: recent progress and future directions. Clinical Infectious Diseases22, 5133–44.

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adjunctive Single-Dose Liposomal Amphotericin to Prevent Cryptococcal Meningitis in People With Human Immunodeficiency Virus (HIV)–Associated Cryptococcal Antigenemia and Low Plasma Cryptococcal Antigen (CrAg) Titers;Clinical Infectious Diseases;2024-07-24

2. Repurposing Amphotericin B and Its Liposomal Formulation for the Treatment of Human Mpox;International Journal of Molecular Sciences;2023-05-17

3. Amphotericin B: A drug of choice for Visceral Leishmaniasis;Acta Tropica;2022-11

4. Checkpoint inhibitors as immunotherapy for fungal infections: Promises, challenges, and unanswered questions;Frontiers in Immunology;2022-10-25

5. Antileishmanial Agents Co-loaded in Transfersomes with Enhanced Macrophage Uptake and Reduced Toxicity;AAPS PharmSciTech;2022-08-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3